Thematic investing

Healthy Living

Good health is increasingly recognized as a powerful human and economic asset. Beyond improving the quality of life, it helps individuals remain independent, active, and engaged – enabling sustained vitality throughout all of life’s stages.

  • 12.5

    USD trillion, potential boost in global GDP by 2050 from improved health1

  • 40

    years increase in life expectancy in Asia over the past 100 years, reaching now an average of 75 years2

  • +22%

    increase in employment rate for ages 60-64 across OECD, 2004-20243

The global economy is entering a new era, defined by longer lives and lower birth rates. Health is no longer just about treating illnesses, but increasingly about maximizing wellbeing and extending healthy years, enabling people to contribute to society for longer. By living longer and stronger, individuals can achieve their full potential, driving a more productive workforce, stronger communities and more resilient economic growth. Healthy living is therefore central to solving the demographic dilemma of longevity while unlocking economic opportunities.

Why invest in healthy living?

In a world of longer lives and lower birth rates, the focus is shifting from healthcare as a cost center toward health as an asset with a very high return on investment.

Enhancing global health could generate approximately 288 million additional full-time-equivalent work years by 2050, more than twice the current US labor force (McKinsey Health Institute). As older populations become the primary source of labor force growth in developed markets, this transition requires reimagining longevity – not as a drag on output but as an underutilized source of growth.

Technology is rapidly evolving as a key enabler in this transition. Healthcare is becoming one of the most compelling real-world applications of AI, rapidly powering enhancements in drug discovery, diagnostics, clinical decision-making and operational efficiency.

Far from the clinics and labs, in factories and warehouses, automation and productivity technologies are reducing the intensity of work, enabling older workers to participate in the workforce for longer.

Meanwhile, consumer empowerment and intensifying demand for prevention is driving growth in the USD 6.8 trillion wellbeing economy.

Longevity is also creating opportunities in the financial sector. As individuals live and work longer, demand for life, health and retirement-related insurance is increasing globally, financial solution providers are poised to benefit.

A diagnostic revolution in health

The strategy

Healthy Living goes far beyond traditional healthcare, investing across nutrition, physical wellbeing, prevention, and technological innovation. Recognizing that individuals need clean environments and financial security to thrive, the strategy also invests in companies that promote environmental safety, workforce productivity and life-long financial resilience.

The strategy is exposed to companies that may benefit from the accelerating real-world adoption of artificial intelligence, particularly in healthcare, in life sciences, health services and the workplace, where AI is advancing drug discovery and diagnostics, and human productivity.

Keep your portfolio fit for the future with an investment in Healthy Living.

Healthy Living D USD

performance ytd (31-8)
-4.21%
Performance 3y (31-8)
0.64%
morningstar (31-8)
1 / 5
SFDR (31-8)
Article 9
Dividend Paying (31-8)
No
View the fund
Past performance is no guarantee of future results. The value of the investments may fluctuate. Annualized (for periods longer than one year). Performances are net of fees and based on transaction prices.

Footnotes

1How investing in population health fuels global growth | McKinsey
2Treating longevity with healthcare in Asia | McKinsey
3Changes in employment rates of older workers: Pensions at a Glance 2025 | OECD

Related insights

See all

Thematic investing

Open your portfolio to the power of themes

Overview

Let's keep the conversation going

Keep track of fast-moving events in sustainable and quantitative investing, trends and credits with our newsletters.

Don’t miss out

Robeco aims to enable its clients to achieve their financial and sustainability goals by providing superior investment returns and solutions.

Important information
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor.


Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States. This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.